Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System

NACompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2019

Conditions
Coronary Artery Disease
Interventions
DEVICE

Coronary Stenting

Trial Locations (18)

Unknown

OLV Ziekenhuis Aalst, Aalst

Middelheim Ziekenhuis, Antwerp

ZOL Genk, Genk

CHU Liège, Liège

Všeobecná fakultní nemocnice Praha, Prague

Clinique Saint-Hilaire, Rouen

CHU de Toulouse, Toulouse

Clinique Pasteur, Toulouse

Medizinisches Verzorgungszentrum Prof. Mathey, Prof. Schofer, Hamburg

University Medical Center Hamburg-Eppendorf, Hamburg

OLVG Amsterdam, Amsterdam

Catharina Hospital Eindhoven, Eindhoven

Erasmus MC, Rotterdam

Maasstad Ziekenhuis, Rotterdam

University Medical Center Utrecht, Department of Cardiology, Utrecht

Skane University Hospital, Malmo

Södersjukhuset, Stockholm

Inselspital, Bern

All Listed Sponsors
lead

Svelte Medical Systems, Inc.

INDUSTRY

NCT01788150 - Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System | Biotech Hunter | Biotech Hunter